References
- Dahl L K, Heine M, Tassinari L F. Effects of chronic excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J. Exper. Med 1962; 115: 1173–1190
- Friedman R. Experimental psychogenic hypertension. Stress and the heart. 2nd ed, D Wheatley. Raven Press, New York 1981; 209–228
- Rapp J P, Dene H. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertens 1984; 7: 340–349
- Takeshita A, Mark A L. Neurogenic contribution to hindquarters vasoconstriction during high sodium intake in the Dahl strain of genetically hypertensive rat. Circ. Res 1978; 43 Suppl 1: 86–91
- Fink G D, Takeshita A, Mark A L, Brody M J. Determinants of renal vascular resistance in the Dahl strain of genetically hypertensive rat. Hypertens 1980; 2: 274–280
- Edwards F, McCaughran J A, Jr, Friedman R, McNally W, Schechter N. Cholinergic receptor site binding, choline acetyltransferase, and acetylcholinesterase activity in the forebrain and brainstem of the Dahl rat model of essential hypertension. Clin. Exper. Hyper.-Theory and Practice 1983; 5(10)1683–1702
- McCaughran J A, Jr, Murphy D, Schechter N, Friedman R. Participation of the central cholinergic system in blood pressure regulation in the Dahl rat model of essential hypertension. J. Cardiovasc. Pharmacol 1983; 5: 1005–1009
- McCaughran J A, Jr, Juno C J, Friedman R. Pre- and neonatal exposure of the Dahl rat to NaCl: Development and regional distribution of myocardial α1-adrenergic and cholinergic receptor sites. J. Autonom. Nerv. Syst 1986, in press
- Harrison S D, Bosin T R, Maickel R P. Physiological disposition of atropine in the rat. Pharmacol. Biochem. Behav 1974; 2: 843
- Delbarre B, Schtnitt H. Effects of clonidine and some - adrenoceptor blocking agents in avoidance conditioned reflexes in rats: their interactions and antagonism by atropine. Psychopharmacologia 1974; 35: 195
- Izquierdo I. Possible peripheral adrenergic and cholinergic mechanisms in pseudoconditioning. Psychopharmacologia 1974; 35: 189
- Brezenoff H E, Giuliano R. Cardiovascular control by cholinergic mechanisms in the central nervous system. Ann. Rev. Pharmacol. and Toxicol 1982; 22: 341
- Buccafusco J J, Spector S. Role of central cholinergic neurons in experimental hypertension. J. Cardiovasc. Pharmacol 1980; 2: 347–355
- Kubo T, Tatsumi M. Increased pressor response to physostigmine in spontaneously hypertensive rats. Naunyn-Schmiedebergs Arch. Pharmacol 1979; 306: 81–83
- Takeshita A, Mark A L, Brody M J. Prevention of salt-induced hypertension in the Dahl strain by 6-hydroxydopamine. Am. J. Physiol 1979; 236: H48–H52
- Friedman R, Tassinari L J, Heine M, Iwai J. Differential development of salt-induced and renal hypertension in Dahl hypertension-sensitive rats after neonatal sympathectomy. Clin. Exp. Hypertens 1979; 1: 779–799
- Buccafusco J J, Brezenoff H E. Pharmacologic study of a cholinergic mechanism within the rat posterior hypothalamic nucleus which mediates a hypertensive response. Brain Res 1979; 165: 295–310
- Buccafusco J J, Finberg J P. H, Spector S. Mechanism of the antihypertensive action of clonidine on the pressor response to physostigmine. J. Pharmacol. Exp. Ther 1980; 212: 58–83
- Varagic T, Kazic V M. The acute effect of 6-hydroxydopamine on the blood pressure response to eserine and tyramine in the rat. Neuropharmacol 1970; 9: 97–102
- Kaul C L, Grewal R S. Physostigmine and 1,1-dimethyl-4-phenylpiperazinium-induced pressor responses and catecholamine release in 6-hydroxydopamine-treated rats. Eur. J. Pharmacol 1972; 18: 261–265
- Whishaw I Q, O'Connor W T, Dunnett S B. Disruption of central cholinergic systems in the rat by basal forebrain lesions or atropine: Effects on feeding, sensorimotor behaviour, locomotor activity and spatial navigation. Behav Brain Res 1985; 17: 103–115
- Chalmers J P. Brain amines and models of hypertension. Circ. Res 1975; 36: 469–480